|
| |
| | | 63255 | | 01.10.2013 | | CPS Cito Pharma Services GmbH | | | | | | | | | | | | | 01.05. | | | | 01.05. | | FI |
| | Seq.-Nr. | Präparat | Beschreibung | Galenische Form | ATC-Klassierung | |
|---|
| 01 | Sequase XR 50 mg | Retardtabletten | Retard-Tabletten (Quetiapin 50 mg) | N05AH04 | PI | | 02 | Sequase XR 150 mg | Retardtabletten | Retard-Tabletten (Quetiapin 150 mg) | N05AH04 | PI | | 03 | Sequase XR 200 mg | Retardtabletten | Retard-Tabletten (Quetiapin 200 mg) | N05AH04 | PI | | 04 | Sequase XR 300 mg | Retardtabletten | Retard-Tabletten (Quetiapin 300 mg) | N05AH04 | PI | | 05 | Sequase XR 400 mg | Retardtabletten | Retard-Tabletten (Quetiapin 400 mg) | N05AH04 | PI |
|
|
|
